Sandeep Chidambar Kulkarni - 24 Oct 2023 Form 4 Insider Report for Tourmaline Bio, Inc. (TRML)

Role
CEO, Director
Signature
/s/ Brad Middlekauff, Attorney-in-Fact
Issuer symbol
TRML
Transactions as of
24 Oct 2023
Net transactions value
+$110,912
Form type
4
Filing time
26 Oct 2023, 17:34:16 UTC
Previous filing
23 Oct 2023
Next filing
20 Nov 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TALS Common Stock Purchase $49,662 +4,650 +0.65% $10.68 720,735 24 Oct 2023 Direct
transaction TALS Common Stock Purchase $61,250 +5,000 +0.69% $12.25 725,735 26 Oct 2023 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.